Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GXIPC 1

Next Previous
Drug Profile

GXIPC 1

Alternative Names: Adipose derived messenchymal stem cell therapy - Gwoxi Stem cell applied technology; GXIPC-1

Latest Information Update: 28 Nov 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GWOXI Stem Cell Applied Technology
  • Class Mesenchymal stem cell therapies
  • Mechanism of Action Cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Type 1 diabetes mellitus

Most Recent Events

  • 28 Nov 2024 No recent reports of development identified for phase-I development in Type-1 diabetes mellitus(In adolescents, In children, In the elderly, In adults) in Vietnam (IV)
  • 01 Apr 2022 GXIPC 1 - Gwoxi Stem cell applied technology is available for licensing as of 01 Apr 2022. https://trpma.org.tw/eng/join (Gwoxi Stem cell applied technology pipeline, April 2022)
  • 04 Oct 2021 Phase-I clinical trials in Type 1 diabetes mellitus (In children, In adolescents, In adults, In the elderly) in Vietnam (IV) (NCT05308836)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top